| By Business Wire |
Article Rating: |
|
| March 22, 2013 01:36 AM EDT |
Reads: |
287 |
Medrobotics Corporation, an emerging medical robotics company developing
the innovative Flex™ Robotic System, announced the recent closing
of up to $10 Million in new debt financing from Hercules Technology III,
L.P., an affiliate of Hercules Technology Growth Capital, Inc. The
financing precedes Medrobotics’ anticipated commercial launches in
Europe and the United States.
About Medrobotics
Medrobotics Corporation (www.Medrobotics.com)
is a privately-held company headquartered in Raynham, Massachusetts that
is developing and commercializing the Flex™ Robotic System, a
robotic-assist platform that enables surgeons to gain single-site access
and visualization to difficult-to-access anatomical locations. The robot
provides a precise and stable platform for enhanced visualization and
enables two-handed dexterity with compatible third-party instruments
having tactile feedback.
About Hercules Technology Growth Capital
Hercules Technology Growth Capital, Inc. (NYSE: HTGC) ("Hercules") (www.HTGC.com)
is the leading specialty finance company focused on providing senior
secured loans to venture capital-backed companies in technology-related
markets, including technology, biotechnology, life science and cleantech
industries at all stages of development. Since inception (December
2003), Hercules has committed more than $3.4 billion to over 220
companies and is the lender of choice for entrepreneurs and venture
capital firms seeking growth capital financing.
Hercules' common stock trades on the New York Stock Exchange (NYSE)
under the ticker symbol "HTGC."
In addition, Hercules has two outstanding bond issuances of 7.00% Senior
Notes due 2019—the April 2019 Notes and September 2019 Notes—which trade
on the NYSE under the symbols “HTGZ” and “HTGY,” respectively.
